Greenwood B. The contribution of vaccination to global health: past, present and future. Philos Trans R Soc B Biol Sci. 2014;369(1645):20130433.

Article  Google Scholar 

Largeron N, Lévy P, Wasem J, Bresse X. Role of vaccination in the sustainability of healthcare systems. J Mark Access Health Polic. 2015;3(1):27043.

Article  Google Scholar 

Islami F, Ward EM, Sung H, Cronin KA, Tangka FK, Sherman RL, et al. 2021 Annual report to the nation on the status of cancer, part 1: national cancer statistics. JNCI: Journal of the National Cancer Institute 113 (12):1648–69

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discovery. 2019;18(3):175–96.

Article  CAS  PubMed  Google Scholar 

Said SS, Ibrahim WN. Cancer resistance to immunotherapy: comprehensive insights with future perspectives. Pharmaceutics. 2023;15(4):1143.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ventola CL. Cancer Immunotherapy, part 1: current strategies and agents. Pharm Ther. 2017;42(6):375–83.

Google Scholar 

Waldman AD, Fritz JM, Lenardo MJ. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat Rev Immunol. 2020;20(11):651–68.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sahin U, Türeci Ö. Personalized vaccines for cancer immunotherapy. Science. 2018;359(6382):1355–60.

Article  ADS  CAS  PubMed  Google Scholar 

Mattiuzzi C, Lippi G. Current Cancer Epidemiology. J Epidemiol Glob Health. 2019;9(4):217–22.

Article  PubMed  PubMed Central  Google Scholar 

Zhang H, Chen J. Current status and future directions of cancer immunotherapy. J Cancer. 2018;9(10):1773.

Article  PubMed  PubMed Central  Google Scholar 

DePinho RA. The age of cancer. Nature. 2000;408(6809):248–54.

Article  ADS  CAS  PubMed  Google Scholar 

Henley SJ, Thomas CC, Lewis DR, Ward EM, Islami F, Wu M, et al. Annual report to the nation on the status of cancer, part II: progress toward Healthy People 2020 objectives for 4 common cancers. Cancer. 2020;126(10):2250–66.

Article  PubMed  Google Scholar 

Tojjari A, Saeed A, Singh M, Cavalcante L, Sahin IH, Saeed A. A comprehensive review on cancer vaccines and vaccine strategies in hepatocellular carcinoma. Vaccines. 2023;11(8):1357.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tay BQ, Wright Q, Ladwa R, Perry C, Leggatt G, Simpson F, et al. Evolution of cancer vaccines—challenges, achievements, and future directions. Vaccines. 2021;9(5):535.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Donninger H, Li C, Eaton JW, Yaddanapudi K. Cancer vaccines: promising therapeutics or an unattainable dream. Vaccines. 2021;9(6):668.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Crews DW, Dombroski JA, King MR. Prophylactic cancer vaccines engineered to elicit specific adaptive immune response. Front Oncol. 2021;11:626463.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Elsheikh R, Makram AM, Huy NT. Therapeutic cancer vaccines and their future implications. Vaccines. 2023;11(3):660.

Article  PubMed  PubMed Central  Google Scholar 

Liu J, Fu M, Wang M, Wan D, Wei Y, Wei X. Cancer vaccines as promising immuno-therapeutics: platforms and current progress. J Hematol Oncol. 2022;15(1):28.

Article  PubMed  PubMed Central  Google Scholar 

Zhou H, Ma Y, Liu F, Li B, Qiao D, Ren P, et al. Current advances in cancer vaccines targeting NY-ESO-1 for solid cancer treatment. Front Immunol. 2023;14:1255799.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vergati M, Intrivici C, Huen N-Y, Schlom J, Tsang KY. Strategies for cancer vaccine development. J Biomed Biotechnol. 2010;2010

Article  PubMed  PubMed Central  Google Scholar 

Shackleton M. Normal stem cells and cancer stem cells: similar and different. Semin Cancer Biol. 2010;20(2):85–92.

Article  CAS  PubMed  Google Scholar 

Bray F, Laversanne M, Weiderpass E, Soerjomataram I. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 2021;127(16):3029–30.

Article  PubMed  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

Article  PubMed  Google Scholar 

Arjmand B, Hamidpour SK, Alavi-Moghadam S, Yavari H, Shahbazbadr A, Tavirani MR, et al. Molecular docking as a therapeutic approach for targeting cancer stem cell metabolic processes. Front Pharmacol. 2022;13:768556.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Soerjomataram I, Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070. Nat Rev Clin Oncol. 2021;18(10):663–72.

Article  PubMed  Google Scholar 

Berben L, Floris G, Wildiers H, Hatse S. Cancer and aging: two tightly interconnected biological processes. Cancers. 2021;13(6):1400.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Collaborators GBDCRF. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022;400(10352):563–91.

Article  Google Scholar 

Chen S, Cao Z, Prettner K, Kuhn M, Yang J, Jiao L, et al. Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050. JAMA Oncol. 2023;9(4):465–72.

Article  PubMed  PubMed Central  Google Scholar 

Mansouri V, Beheshtizadeh N, Gharibshahian M, Sabouri L, Varzandeh M, Rezaei N. Recent advances in regenerative medicine strategies for cancer treatment. Biomed Pharmacother. 2021;141:111875.

Article  CAS  PubMed  Google Scholar 

Kohl KS, Gidudu J, Bonhoeffer J, Braun MM, Buettcher M, Chen RT, et al. The development of standardized case definitions and guidelines for adverse events following immunization. Vaccine. 2007;25(31):5671–4.

Article  CAS  PubMed  Google Scholar 

Hammerstrom AE, Cauley DH, Atkinson BJ, Sharma P. Cancer immunotherapy: sipuleucel-T and beyond. J Human Pharmacol Drug Ther. 2011;31(8):813–28.

Article  Google Scholar 

Anassi E, Ndefo UA. Sipuleucel-T (provenge) injection: the first immunotherapy agent (vaccine) for hormone-refractory prostate cancer. Pharm Ther. 2011;36(4):197–202.

Google Scholar 

Singh J, Bowne WB, Snook AE. Cancer vaccines and immunotherapy for tumor prevention and treatment. Vaccines. 2021;9(11):1298.

Article  PubMed  PubMed Central  Google Scholar 

Athanasiou A, Bowden S, Paraskevaidi M, Fotopoulou C, Martin-Hirsch P, Paraskevaidis E, et al. HPV vaccination and cancer prevention. Best Pract Res Clin Obstet Gynaecol. 2020;65:109–24.

Article  CAS  PubMed  Google Scholar 

Thomas S, Prendergast GC. Cancer vaccines: a brief overview. Methods Mol Biol. 2016;1403:755–61.

Article  PubMed  Google Scholar 

Maeng HM, Berzofsky JA Strategies for developing and optimizing cancer vaccines. F1000 Res. 2019 8

Chen DS, Mellman I. Elements of cancer immunity and the cancer–immune set point. Nature. 2017;541(7637):321–30.

Article  ADS  CAS  PubMed  Google Scholar 

Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science. 2011;331(6024):1565–70.

Article  ADS  CAS  PubMed  Google Scholar 

Kishi M, Asgarova A, Desterke C, Chaker D, Artus J, Turhan AG, et al. Evidence of antitumor and antimetastatic potential of induced pluripotent stem cell-based vaccines in cancer immunotherapy. Front Med. 2021;8: 729018.

Article  Google Scholar 

Itoh K, Yamada A, Mine T, Noguchi M. Recent advances in cancer vaccines: an overview. Jpn J Clin Oncol. 2009;39(2):73–80.

Article  PubMed  Google Scholar 

Arjmand B, Alavi-Moghadam S, Aghayan HR, Rezaei-Tavirani M, Goodarzi P, Tayanloo-Beik A, et al. How to establish infrastructures to achieve more efficient regenerative medicine? Cell Tissue Bank. 2023;24(1):1–9.

Article